Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Septin 14 pseudogene 6 (SEPTIN14P6) is a non-protein-coding pseudogene related to the septin 14 gene family. Pseudogenes like SEPTIN14P6 arise from gene duplication or retrotransposition events but have lost their ability to encode functional proteins due to disabling mutations. While considered “junk DNA” in the past, mounting evidence indicates that some pseudogenes can be transcribed into RNA, sometimes exhibiting tissue-specific patterns. These RNA transcripts can modulate gene expression of their parent or related genes, for instance by acting as competing endogenous RNAs (ceRNAs) that sequester microRNAs, functioning as siRNA precursors, or affecting mRNA stability. Such roles have been described for other pseudogenes, especially in contexts like cancer[1][3]. However, there is no specific evidence for direct regulatory or pathological significance of SEPTIN14P6 itself in the available literature.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Septin 14 pseudogene 6 (SEPTIN14P6).